Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.26
-0.01 (-0.31%)
At close: Aug 18, 2025, 2:38 PM
Psyence Biomedical Cash Flow Statement
Financials in CAD. Fiscal
year is
undefined.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -759.86K | 1.52M | 2.93M | 5.04M | 8.01M | 14.07M | 13.26M | 11.22M | 8.26M | -45.06K |
Depreciation & Amortization | 0.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 158.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 787.38K | 383.39K | 148.99K | 56.31K | -54.44K | -215.18K | -241.37K | -409.36K | -519.88K | 45K |
Other Non-Cash Items | -1.85M | -3.81M | -4.83M | -7.48M | -8.48M | -15.11M | -14.19M | -11.85M | -8.57M | -6.83K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 787.37K | 383.39K | 148.99K | 824.22K | -54.44K | -215.18K | -241.37K | -409.36K | -519.88K | 45K |
Operating Cash Flow | -1.05M | -1.14M | -979.84K | -853.45K | -519.6K | -1.25M | -1.17M | -1.04M | -826.56K | -6.88K |
Capital Expenditures | -6.86 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -595.17K | -595.17K | -495K | -247.5K | n/a | -255M | -255M | -255M | -255M | n/a |
Sales Maturities Of Investments | 247.42M | 247.42M | 243.11M | 243.11M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 246.83M | 246.83M | 242.62M | 242.86M | n/a | -255M | -255M | -255M | -255M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -31.83K | n/a | n/a | n/a | 31.83K |
Common Stock Repurchased | -247.42M | -247.42M | -243.11M | -243.11M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.61M | 1.61M | 1.18M | 685K | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -245.81M | -245.81M | -241.93M | -242.43M | n/a | 256.46M | 256.46M | 256.46M | 256.46M | 6.83K |
Net Cash Flow | -40.43K | -126.76K | -297.07K | -415.95K | -519.61K | 205.02K | 296.9K | 421.93K | 638.31K | -57 |
Free Cash Flow | -1.05M | -1.14M | -979.84K | -853.45K | -519.6K | -1.25M | -1.17M | -1.04M | -826.56K | -6.88K |